Using the BiovitalsHF software to personalize recommendations got more patients on all four pillars of therapy.

Reprieve Cardiovascular, Inc., a development-stage company focused on advancing acute decompensated heart failure (ADHF) ...

Heart transplant is a scary and serious surgery with a high cost, but for patients with heart failure it can be the only ...

There are many difficulties in converting any biological research into a medicine that will treat patients. Because of the ...

Heart transplant is a scary and serious surgery with high cost, but for patients with heart failure it can be the only option for cure.

The addition of β-adrenergic antagonists to the treatment regimen for heart failure has validated the neurohormonal hypothesis and provided much-improved outcomes. This benefit had been in ...

The European Commission (EC) has granted marketing authorisation to BridgeBio Pharma’s selective small molecule, acoramidis, ...

The main results of the SUMMIT trial, reported last year, showed that tirzepatide—a dual glucose-dependent insulinotropic ...

This review discusses the role of aldosterone antagonists in the treatment of heart failure, including an overview of aldosterone’s role in the pathology of heart failure, the benefits of each ...

Peripartum cardiac insufficiency (PPCM) is a rare but life-threatening condition that can affect previously heart-healthy ...

In February 2024, Corewell Health introduced pulsed field ablation, a treatment procedure significantly safer than previous AFib treatments, at several of its Michigan hospitals. PFA applies a ...

A team of physicists has developed a groundbreaking method for detecting congestive heart failure with greater ease and precision than previously thought possible. This multidisciplinary study, ...